Effect of canonical aryl hydrocarbon receptor pathway inhibitor on human umbilical vein endothelial cells
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP479519
下载链接
链接失效反馈官方服务：
资源简介：
To study the effect of blockade of canonical aryl hydrocarbon receptor (AHR) pathway in human endothelial cells, we treated human umbilical vein endothelial cells (HUVECs) with a canonical AHR inhibitor, Stemreginin 1 (SR1) and performed bulk RNAseq analysis. Overall design: Samples were derived from 3 individual patients. Cells from each patient were treated with either 1: 10, 000 DMSO (vehicle), or 0.5uM SR1 in 1: 10, 000 DMSO. After 48 hours, RNA samples were collected for comparisons.
创建时间：
2024-07-01
